SPARCL1 and colorectal carcinoma: Among them, MYL9 and CNN1 were previously characterized by other groups as CRC recurrence-correlated genes (Qiu et al., 2020), while the others (TIMP1, SPARCL1, and TPM2) have never been reported before.